Circulation of rare events in the liquid biopsy for early detection of lung mass lesions
The data support the utility of the LBx in distinguishing patients with an alveolar lesion from those without, providing a potential avenue for prescreening before LDCT.
Authors
- Peter Kühn (ORCID: https://orcid.org/0000-0003-2629-4505)
- Karen Resnick
- Jeremy M. Mason (ORCID: https://orcid.org/0000-0002-5933-5003)
- Stephanie N. Shishido (ORCID: https://orcid.org/0000-0002-5949-0687)
- Jorge J. Nieva (ORCID: https://orcid.org/0000-0003-1605-4719)
- Anya Shah
Institutions
- University of Southern California (US)
- Convergent Science (United States) (US)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1111/1759-7714.15429
- Citations
- 3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- USC Norris Comprehensive Cancer Center
- National Institutes of Health
- National Cancer Institute